Sulfadiazine Sodium

CHEMBL1200351 Phase 4 承認済み Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

272.3 g/mol

LogP

—

Phase

4

A sodium salt form of sulfadiazine with the same therapeutic properties. A sulfonamide antibiotic used primarily to treat toxoplasmosis — a parasitic infection that can be life-threatening in people with HIV or weakened immune systems — typically in combination with pyrimethamine.

分子量

272.2600 g/mol

TPSA

95.30 Å²

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure

Embed this structure

SMILES

Nc1ccc(S(=O)(=O)[N-]c2ncccn2)cc1.[Na+]

InChI

InChI=1S/C10H9N4O2S.Na/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10;/h1-7H,11H2;/q-1;+1

Molecular Formula

C10H9N4NaO2S

HBD / HBA

1 / 6

回転可能結合数

3

重原子数

18

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

A sodium salt form of sulfadiazine with the same therapeutic properties. A sulfonamide antibiotic used primarily to treat toxoplasmosis — a parasitic infection that can be life-threatening in people with HIV or weakened immune systems — typically in combination with pyrimethamine.

Yes, Sulfadiazine Sodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200351. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 15899898. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

患者向けのわかりやすい情報をお探しですか？

Sulfadiazine Sodium PillFYIで

構造

クイックデータ

分子式: C10H9N4NaO2S

外部リンク

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.